🔎 Trials Near Me

Domov › Rakovina močového mechúra › Kalifornia › Los Angeles

Klinické štúdie Rakovina močového mechúra v meste Los Angeles, CA

24 štúdií pre Rakovina močového mechúra hľadá účastníkov v zariadeniach v meste Los Angeles a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Prebieha náborFáza 2
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06770582

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Prebieha náborFáza 1
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Prebieha náborFáza 2
  • USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Prebieha náborFáza 2
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07061964

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Prebieha náborFáza 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07090499

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Prebieha náborFáza 2
  • Keck Medicine of USC Koreatown, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Prebieha náborFáza 1/2
  • START Los Angeles, LLC, Los Angeles
  • Los Angeles Cancer Network - Century City, Los Angeles
  • (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
  • a 1 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Prebieha náborFáza 3
  • TRIO-US (Translational Research in Oncology-US), Los Angeles
  • UCLA Hematology/Oncology - Santa Monica, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07218380

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Prebieha náborFáza 1
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07217171

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Prebieha náborFáza 2/3
  • Research Site, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07129993

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Prebieha náborFáza 1
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT05614739

A Study of MGC026 in Participants With Advanced Solid Tumors

Prebieha náborFáza 1
  • The Angeles Clinic and Research Institute, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06242470

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Prebieha náborFáza 1/2
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Tower Urology, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT04752722

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Prebieha náborFáza 2
  • UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
  • Kaiser Permanente Los Angeles Medical Offices, Los Angeles
  • Kaiser Permanente West Los Angeles Medical Center, Los Angeles
  • a 6 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT04879329

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

Prebieha náborFáza 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07337525

Predicting BCG Response

Prebieha náborObservačná štúdia
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA, Los Angeles
Vek 18 až 90 · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT04564781

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Prebieha náborFáza 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • The Regents of the University of California, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT04389632

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Prebieha nábor
  • Urology Group of Southern California, Los Angeles
  • Comprehensive Urology, Los Angeles
Vek 18 až 88 · Všetky pohlavia · Aktualizované 2. 7. 2026 · NCT06394869

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Prebieha náborFáza 1
  • USC - Norris Comprehensive Cancer Center, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT06778863

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Prebieha náborObservačná štúdia
  • Cedars-Sinai Medical Center, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 2. 2026 · NCT03193515

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Prebieha náborObservačná štúdia
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA Medical Center, Los Angeles
Vek 18 až 90 · Všetky pohlavia · Aktualizované 4. 2. 2026 · NCT03193541

Blue Light Cystoscopy With Cysview® Registry

Prebieha náborObservačná štúdia
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • University of California Los Angeles, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 12. 2025 · NCT02660645

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Prebieha nábor
  • Cedars-Sinai Medical Center (CSMC), Los Angeles
  • University of California Los Angeles, Los Angeles
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 8. 2025 · NCT04442724

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Prebieha nábor
  • UCLA, Los Angeles
Vek 18 až 70 · Všetky pohlavia · Aktualizované 12. 2. 2025 · NCT06337942

Štúdie Rakovina močového mechúra v iných mestách

Iné štúdie v Los Angeles

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.